In April 2013, the semi-synthetic artemisinin project reached the conclusion of it saga — commercial launch. Officials from Sanofi, its partners, the malaria community and the Italian government gathered with local, national and international press at Sanofi’s plant in Garessio, Italy to witness the culmination of this multi-year project.
